Cingulate EVP granted conditional stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cingulate Inc. EVP and CSO Raul R. Silva received two stock option grants on July 16, 2026. One covers 53,600 shares and the other 26,400 shares of common stock at an exercise price of $4.4300 per share, expiring July 16, 2036. Both vest 25% on March 31, 2027 and then in substantially equal monthly installments over 36 months. The second grant becomes exercisable only if the issuer’s NDA for CTx-1301 is approved by the FDA during 2027; otherwise that option, including any vested portion, terminates.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to Buy) F1 | 53,600 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to Buy) F1, F2, F3 | 26,400 | $0.00 | $0.00 |
Footnotes (3)
- F1. The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.
- F2. Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027.
- F3. If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate.
Key Figures
Key Terms
Stock Option (right to Buy) financial
NDA regulatory
CTx-1301 medical
vests financial
exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did Cingulate (CING) grant to EVP Raul R. Silva?
What is the vesting schedule for Raul R. Silva’s Cingulate (CING) option grants?
How is FDA NDA approval linked to one of the Cingulate (CING) option grants?
Were Raul R. Silva’s Cingulate (CING) option transactions purchases or sales?
Were these Cingulate (CING) option grants made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.